abstract |
Provided are: a means for efficiently producing a large amount of an anti-LR11 antibody; and an LR11 standard for immunoassay.nSpecifically provided is a method for producing an anti-LR11 antibody, which is characterized by using an LR11 that is derived from malignant tumor cells or from urine. |